Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus
Status:
Terminated
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how the body absorbs and chemically changes a
single infusion of TRU-015 in subjects with kidney disease caused by lupus.